Explore a panel discussion on the current state of cancer care, examining achievements, pressing barriers, and groundbreaking discoveries applicable to other diseases. Delve into topics such as the blurring line between clinical practice and research, investments in data, networked centers of excellence, and research community efforts. Learn from experts as they discuss melanoma mortality rates, the National Cancer Institute budget, cancer science innovation, patient priorities, collaboration challenges, data sharing issues, regulatory environments, drug development, machine learning applications, and predictive oncology. Gain insights from industry leaders, researchers, and advocates as they address the evolving landscape of bioscience, using cancer as a case study to illustrate cutting-edge advancements and future directions in healthcare.
A Journey to the Cutting Edge of Bioscience - Cancer as a Case Study
Overview
Syllabus
Introduction
Are we in a better place
Are we on unstable footing
Melanoma mortality rates
National Cancer Institute budget
Cancer science discovery innovation
We are forced to keep running
What drives patients
Are we prioritizing patients
Are we working together enough
Possible ways of intervening
What does good look like
How are we collaborating
Data sharing
Data is messy
Sharing data
Consortium fatigue
Barriers to sharing
Patients dont think were going too quickly
Regulatory environment
Thinking outside the box
Integration
Drug Development
Machine Learning
Preclinical Data
New Technologies New Disciplines
Predictive oncology
Tony Rivas
Dr Michael Smith
National Cancer Institute
Taught by
Milken Institute
